Literature DB >> 21153371

Luciferase protein complementation assays for bioluminescence imaging of cells and mice.

Gary D Luker1, Kathryn E Luker.   

Abstract

Protein fragment complementation assays (PCAs) with luciferase reporters currently are the preferred method for detecting and quantifying protein-protein interactions in living animals. At the most basic level, PCAs involve fusion of two proteins of interest to enzymatically inactive fragments of luciferase. Upon association of the proteins of interest, the luciferase fragments are capable of reconstituting enzymatic activity to generate luminescence in vivo. In addition to bi-molecular luciferase PCAs, unimolecular biosensors for hormones, kinases, and proteases also have been developed using target peptides inserted between inactive luciferase fragments. Luciferase PCAs offer unprecedented opportunities to quantify dynamics of protein-protein interactions in intact cells and living animals, but successful use of luciferase PCAs in cells and mice involves careful consideration of many technical factors. This chapter discusses the design of luciferase PCAs appropriate for animal imaging, including construction of reporters, incorporation of reporters into cells and mice, imaging techniques, and data analysis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21153371      PMCID: PMC4467521          DOI: 10.1007/978-1-60761-901-7_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

1.  Protein-protein interactions monitored in mammalian cells via complementation of beta -lactamase enzyme fragments.

Authors:  Tom Wehrman; Benjamin Kleaveland; Jeng-Horng Her; Robert F Balint; Helen M Blau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Evolution of new nonantibody proteins via iterative somatic hypermutation.

Authors:  Lei Wang; W Coyt Jackson; Paul A Steinbach; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

3.  Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo.

Authors:  Hui Zhao; Timothy C Doyle; Olivier Coquoz; Flora Kalish; Bradley W Rice; Christopher H Contag
Journal:  J Biomed Opt       Date:  2005 Jul-Aug       Impact factor: 3.170

4.  Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system for studying protein-protein interactions.

Authors:  Ramasamy Paulmurugan; Sanjiv S Gambhir
Journal:  Anal Chem       Date:  2007-02-13       Impact factor: 6.986

5.  Molecular imaging of Akt kinase activity.

Authors:  Limin Zhang; Kuei C Lee; Mahaveer S Bhojani; Amjad P Khan; Alla Shilman; Eric C Holland; Brian D Ross; Alnawaz Rehemtulla
Journal:  Nat Med       Date:  2007-08-12       Impact factor: 53.440

6.  An intramolecular folding sensor for imaging estrogen receptor-ligand interactions.

Authors:  Ramasamy Paulmurugan; Sanjiv S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

7.  Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer.

Authors:  Paul T Winnard; Jessica B Kluth; Venu Raman
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

8.  Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging.

Authors:  Katy M Venisnik; Tove Olafsen; Sanjiv S Gambhir; Anna M Wu
Journal:  Mol Imaging Biol       Date:  2007 Sep-Oct       Impact factor: 3.488

9.  Imaging CXCR4 signaling with firefly luciferase complementation.

Authors:  Kathryn E Luker; Mudit Gupta; Gary D Luker
Journal:  Anal Chem       Date:  2008-06-06       Impact factor: 6.986

10.  Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden.

Authors:  Zain Paroo; Robert A Bollinger; Dwaine A Braasch; Edmond Richer; David R Corey; Peter P Antich; Ralph P Mason
Journal:  Mol Imaging       Date:  2004-04       Impact factor: 4.488

View more
  8 in total

1.  Dual-Color Luciferase Complementation for Chemokine Receptor Signaling.

Authors:  Kathryn E Luker; Gary D Luker
Journal:  Methods Enzymol       Date:  2015-11-14       Impact factor: 1.600

2.  Monitoring ligand-dependent assembly of receptor ternary complexes in live cells by BRETFect.

Authors:  David Cotnoir-White; Mohamed El Ezzy; Pierre-Luc Boulay; Marieke Rozendaal; Michel Bouvier; Etienne Gagnon; Sylvie Mader
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-27       Impact factor: 11.205

Review 3.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.

Authors:  Geeta Mehta; Amy Y Hsiao; Marylou Ingram; Gary D Luker; Shuichi Takayama
Journal:  J Control Release       Date:  2012-05-18       Impact factor: 9.776

4.  Split Gaussia luciferase for imaging ligand-receptor binding.

Authors:  Kathryn E Luker; Gary D Luker
Journal:  Methods Mol Biol       Date:  2014

5.  Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration.

Authors:  Jian Zhou; Weiqiang Ju; Dongping Wang; Linwei Wu; Xiaofeng Zhu; Zhiyong Guo; Xiaoshun He
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

Review 6.  In Vivo Analysis of Protein-Protein Interactions with Bioluminescence Resonance Energy Transfer (BRET): Progress and Prospects.

Authors:  Sihuai Sun; Xiaobing Yang; Yao Wang; Xihui Shen
Journal:  Int J Mol Sci       Date:  2016-10-11       Impact factor: 5.923

7.  C3-Luc Cells Are an Excellent Model for Evaluation of Cellular Immunity following HPV16L1 Vaccination.

Authors:  Li-Li Li; He-Rong Wang; Zhi-Yi Zhou; Jing Luo; Xiao-Li Wang; Xiang-Qian Xiao; Yu-Bai Zhou; Yi Zeng
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

8.  Negative Regulation of Interferon-β Production by Alternative Splicing of Tumor Necrosis Factor Receptor-Associated Factor 3 in Ducks.

Authors:  Xiaoqin Wei; Wei Qian; Suolang Sizhu; Yongtao Li; Kelei Guo; Meilin Jin; Hongbo Zhou
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.